In a bold escalation of its ongoing dispute with Harvard University, the Trump administration announced on Friday, August 8, 2025, that it may seize control of the university’s valuable patents derived from federally funded research. This move, led by Commerce Secretary Howard Lutnick, marks a new front in a months-long conflict with the Ivy League institution, centered on allegations of noncompliance with federal patent laws.
Lutnick’s letter to Harvard President Alan Garber outlined an “immediate comprehensive review” to determine whether Harvard has adhered to the requirements of the Bayh-Dole Act of 1980. This legislation allows universities to retain ownership of inventions developed with federal grants, provided they ensure public benefit through commercialization and meet obligations like timely disclosure and U.S.-based manufacturing. The patents in question, potentially worth hundreds of millions of dollars, span innovations in biotechnology, medicine, and engineering, according to a senior administration official.
The Commerce Department has demanded a detailed accounting of all Harvard patents tied to federal funding, including their applications, licensing agreements, and compliance with “substantial U.S. manufacturing” mandates. Harvard has until September 5, 2025, to respond, or risk the government exercising its “march-in” rights under the Bayh-Dole Act, which could result in third-party licensing or outright seizure of the patents.
“We believe Harvard has failed to meet its obligations to the American taxpayer,” Lutnick stated in the letter, accusing the university of breaching statutory, regulatory, and contractual requirements. Failure to comply could lead to significant financial and operational consequences for Harvard, which holds over 5,800 patents and more than 900 active licenses, generating substantial revenue for research and innovation.
Harvard swiftly rebuffed the administration’s claims, labeling the review a “retaliatory effort” aimed at punishing the university for defending its autonomy. “Our technologies and patents are life-saving and industry-redefining,” a Harvard spokesperson said. “We are fully committed to complying with the Bayh-Dole Act and ensuring public access to innovations from our federally funded research.”
This patent dispute is the latest chapter in a broader clash between the Trump administration and Harvard. Since April 2025, the administration has frozen or terminated billions in federal research funding, citing Harvard’s alleged failure to address campus antisemitism. Harvard has responded with lawsuits, arguing that the funding cuts violate its First Amendment rights and represent an attempt to control its academic programs. The administration’s prior demands for external audits, the elimination of DEI initiatives, and stricter disciplinary policies were rejected by Harvard as an overreach.
Additional measures have included a push to review Harvard’s tax-exempt status and an attempt to bar most international students from studying there, though the latter was halted by a federal judge. President Trump has hinted at openness to a settlement, noting that other Ivy League schools like Columbia and Brown have made concessions to restore funding. Reports suggest Harvard considered a $500 million settlement, though university sources dispute this, favoring resolution through ongoing litigation.
The potential use of Bayh-Dole’s march-in rights, never before applied to a major university, could set a precedent with far-reaching implications for academic research. If enforced, it might disrupt Harvard’s licensing agreements, deter industry partnerships, and affect funding for labs and scholarships. As the September 5 deadline looms, the outcome of this high-stakes battle will likely shape the future of federally funded innovation and university-government relations.
This is a developing story, and further updates will be provided as new information emerges.
© 2025 The Boston Proper. All rights reserved. Reproduction or distribution of this material without prior written permission is prohibited.
